4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001774690-26-000004
Chief Financial Officer acquired 14,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Leggett Thomas · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-15 | Exercise or conversion : show line 1 in the form | +14,750 | 14,750 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-15 | Exercise or conversion : show line 2 in the form Restricted Stock Units | −14,750 | 44,250 | D |
Loading xslF345X05/form4-03172026_090359.xml…